<VariationArchive VariationID="1699181" VariationName="NM_001134673.4(NFIA):c.248del (p.Ile83fs)" VariationType="Deletion" Accession="VCV001699181" Version="3" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-30" DateCreated="2022-08-08" MostRecentSubmission="2022-12-24">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1691555" VariationID="1699181">
      <GeneList>
        <Gene Symbol="NFIA" FullName="nuclear factor I A" GeneID="4774" HGNC_ID="HGNC:7784" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1p31.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="61077227" stop="61462788" display_start="61077227" display_stop="61462788" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="61542945" stop="61928459" display_start="61542945" display_stop="61928459" Strand="+" />
          </Location>
          <OMIM>600727</OMIM>
          <Haploinsufficiency last_evaluated="2017-01-12" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=NFIA">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2017-01-12" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=NFIA">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001134673.4(NFIA):c.248del (p.Ile83fs)</Name>
      <CanonicalSPDI>NC_000001.11:61088368:T:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1p31.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="61088369" stop="61088369" display_start="61088369" display_stop="61088369" variantLength="1" positionVCF="61088368" referenceAlleleVCF="AT" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="61554041" stop="61554041" display_start="61554041" display_stop="61554041" variantLength="1" positionVCF="61554040" referenceAlleleVCF="AT" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>I128fs</ProteinChange>
      <ProteinChange>I75fs</ProteinChange>
      <ProteinChange>I83fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.61554041del" Assembly="GRCh37">
            <Expression>NC_000001.10:g.61554041del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.61088369del" Assembly="GRCh38">
            <Expression>NC_000001.11:g.61088369del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011787.2" sequenceAccession="NG_011787" sequenceVersion="2" change="g.16096del">
            <Expression>NG_011787.2:g.16096del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001134673.4" sequenceAccession="NM_001134673" sequenceVersion="4" change="c.248del" MANESelect="true">
            <Expression>NM_001134673.4:c.248del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001128145.1" sequenceAccession="NP_001128145" sequenceVersion="1" change="p.Ile83fs">
            <Expression>NP_001128145.1:p.Ile83fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001145511.2" sequenceAccession="NM_001145511" sequenceVersion="2" change="c.224del">
            <Expression>NM_001145511.2:c.224del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001138983.1" sequenceAccession="NP_001138983" sequenceVersion="1" change="p.Ile75fs">
            <Expression>NP_001138983.1:p.Ile75fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001145512.2" sequenceAccession="NM_001145512" sequenceVersion="2" change="c.383del">
            <Expression>NM_001145512.2:c.383del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001138984.1" sequenceAccession="NP_001138984" sequenceVersion="1" change="p.Ile128fs">
            <Expression>NP_001138984.1:p.Ile128fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005595.5" sequenceAccession="NM_005595" sequenceVersion="5" change="c.248del">
            <Expression>NM_005595.5:c.248del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_005586.1" sequenceAccession="NP_005586" sequenceVersion="1" change="p.Ile83fs">
            <Expression>NP_005586.1:p.Ile83fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2100414350" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001134673.4(NFIA):c.248del (p.Ile83fs) AND Chromosome 1p32-p31 deletion syndrome" Accession="RCV002273038" Version="3">
        <ClassifiedConditionList TraitSetID="10111">
          <ClassifiedCondition DB="MedGen" ID="C3151036">Chromosome 1p32-p31 deletion syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-09-02" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-09-02" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-08-08" MostRecentSubmission="2022-12-24">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">31730271</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="10111" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="15751" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Chromosome 1p32-p31 deletion syndrome</ElementValue>
                <XRef ID="MONDO:0013396" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">For the purposes of this chapter, NFIA-related disorder is defined as heterozygous inactivation or disruption of only NFIA without involvement of adjacent or surrounding genes. NFIA-related disorder comprises central nervous system abnormalities (most commonly abnormalities of the corpus callosum) with or without urinary tract defects, such as unilateral or bilateral vesicoureteral reflux and hydronephrosis. Additional features include macrocephaly, seizures, developmental delay and/or cognitive impairment, nonspecific dysmorphic features, ventriculomegaly, and hypotonia, which can exacerbate motor delay and feeding issues in infancy. Rarer features may include strabismus, cutis marmorata, or craniosynostosis of the metopic, lambdoid, or sagittal suture.</Attribute>
                <XRef ID="NBK542336" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17668" />
                <XRef ID="17668" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">31194316</ID>
                <ID Source="BookShelf">NBK542336</ID>
              </Citation>
              <XRef ID="401986" DB="Orphanet" />
              <XRef ID="C3151036" DB="MedGen" />
              <XRef ID="MONDO:0013396" DB="MONDO" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5003400" SubmissionDate="2022-12-21" DateLastUpdated="2022-12-24" DateCreated="2022-08-08">
        <ClinVarSubmissionID localKey="vcgs/unit_1/hg38_NM_001134673_3_NFIA_c_248delT" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002557594" DateUpdated="2022-12-24" DateCreated="2022-08-08" Type="SCV" Version="2" SubmitterName="Victorian Clinical Genetics Services, Murdoch Childrens Research Institute" OrgID="500104" OrganizationCategory="laboratory" OrgAbbreviation="VCGS" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-09-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">31730271</ID>
          </Citation>
          <Comment>Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with Brain malformations with or without urinary tract defects (MIM#613735; PMID 31730271). (I) 0107 - This gene is associated with autosomal dominant disease. (I) 0201 - Variant is predicted to cause nonsense-mediated decay (NMD) and loss of protein (premature termination codon is located at least 54 nucleotides upstream of the final exon-exon junction). (SP) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0701 - Other nonsense-mediated decay predicted variants comparable to the one identified in this case have very strong previous evidence for pathogenicity (Decipher). (SP) 0807 - This variant has no previous evidence of pathogenicity. (I) 0905 - No published segregation evidence has been identified for this variant. (I) 1007 - No published functional evidence has been identified for this variant. (I) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NFIA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_14373</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001134673.3:c.248delT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="613735" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>submission_32</SubmissionName>
          <SubmissionName>submission_38</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5003400" TraitType="Disease" MappingType="XRef" MappingValue="613735" MappingRef="OMIM">
        <MedGen CUI="CN322312" Name="Brain malformations with or without urinary tract defects" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

